| Literature DB >> 32282914 |
Yvonne Alexander1, Elena Osto2,3, Arno Schmidt-Trucksäss4, Michael Shechter5,6, Danijela Trifunovic7, Dirk J Duncker8, Victor Aboyans9, Magnus Bäck10,11, Lina Badimon12, Francesco Cosentino13, Marco De Carlo14, Maria Dorobantu15, David G Harrison16, Tomasz J Guzik17,18, Imo Hoefer19, Paul D Morris20,21, Giuseppe D Norata22, Rosa Suades13, Stefano Taddei23, Gemma Vilahur12, Johannes Waltenberger24,25, Christian Weber26,27,28,29, Fiona Wilkinson1, Marie-Luce Bochaton-Piallat30, Paul C Evans20,21.
Abstract
Endothelial cells (ECs) are sentinels of cardiovascular health. Their function is reduced by the presence of cardiovascular risk factors, and is regained once pathological stimuli are removed. In this European Society for Cardiology Position Paper, we describe endothelial dysfunction as a spectrum of phenotypic states and advocate further studies to determine the role of EC subtypes in cardiovascular disease. We conclude that there is no single ideal method for measurement of endothelial function. Techniques to measure coronary epicardial and micro-vascular function are well established but they are invasive, time-consuming, and expensive. Flow-mediated dilatation (FMD) of the brachial arteries provides a non-invasive alternative but is technically challenging and requires extensive training and standardization. We, therefore, propose that a consensus methodology for FMD is universally adopted to minimize technical variation between studies, and that reference FMD values are established for different populations of healthy individuals and patient groups. Newer techniques to measure endothelial function that are relatively easy to perform, such as finger plethysmography and the retinal flicker test, have the potential for increased clinical use provided a consensus is achieved on the measurement protocol used. We recommend further clinical studies to establish reference values for these techniques and to assess their ability to improve cardiovascular risk stratification. We advocate future studies to determine whether integration of endothelial function measurements with patient-specific epigenetic data and other biomarkers can enhance the stratification of patients for differential diagnosis, disease progression, and responses to therapy. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: Cardiovascular; Endothelial function
Mesh:
Year: 2021 PMID: 32282914 PMCID: PMC7797212 DOI: 10.1093/cvr/cvaa085
Source DB: PubMed Journal: Cardiovasc Res ISSN: 0008-6363 Impact factor: 10.787